Acquiring a Home Healthcare Business: Industry Playbook

Home healthcare is one of the fastest-growing corners of the US healthcare system, a $150 billion-plus market expanding at 7-9% annually, fueled by an aging population that overwhelmingly prefers to receive care at home rather than in institutional settings. For search fund entrepreneurs, the sector combines powerful demographic tailwinds, recurring government-reimbursed revenue, and extreme fragmentation into a compelling acquisition thesis. Yet home healthcare also carries meaningful regulatory complexity, workforce challenges, and reimbursement risk that demand specialized diligence. This playbook walks through the market environment, deal evaluation, valuation benchmarks, and post-acquisition growth levers you need to acquire, and operate, a home healthcare business successfully. If you are still evaluating whether entrepreneurship through acquisition is the right path, start with our overview of what ETA is and how it works.

The home healthcare market: size and drivers

Total US spending on home health services exceeded $150 billion in 2024, and CMS projects the category will surpass $200 billion before the end of the decade. Several structural forces underpin this growth:

• Aging demographics:The 65-and-over population will grow from roughly 58 million today to 82 million by 2050. This cohort consumes 3-4x more healthcare services per capita than younger age groups, and the preference for aging in place is nearly universal, AARP surveys consistently show that 90% of seniors want to remain in their homes as long as possible.
• Cost advantage over institutional care: A day of home health aide service costs $180-$220, compared with $280-$320 for assisted living and $800+ for a skilled nursing facility. Medicare, Medicaid, and commercial insurers are all actively steering patients toward lower-cost home-based settings, creating a reimbursement tailwind for home health providers.
• Policy momentum:CMS’s “Home Health Value-Based Purchasing” model, expanded telehealth flexibilities, and state Medicaid waiver programs that fund home- and community-based services (HCBS) are all shifting dollars out of facilities and into the home.
• Post-acute care shift:Hospitals face penalties for readmissions within 30 days of discharge. Skilled home health agencies that reduce readmission rates have become essential partners for health systems, locking in referral volume.

Types of home healthcare businesses

“Home healthcare” is an umbrella term that covers several distinct service lines, each with its own regulatory requirements, reimbursement dynamics, and operating profiles. Understanding the differences is critical before you begin sourcing deals.

Skilled home health (Medicare-certified)

Medicare-certified home health agencies (HHAs) provide skilled nursing, physical therapy, occupational therapy, speech-language pathology, and medical social work under a physician’s plan of care. These agencies bill Medicare under the Patient-Driven Groupings Model (PDGM), which assigns a 30-day payment based on clinical characteristics, functional status, and referral source. Average Medicare reimbursement per episode is approximately $2,000-$3,500. Skilled home health is the highest-revenue, highest-margin, and most heavily regulated segment of the market.

Non-medical / companion care

Non-medical home care agencies provide assistance with activities of daily living (ADLs), bathing, dressing, meal preparation, medication reminders, light housekeeping, and companionship. These services are typically paid out of pocket by the patient or family, through long-term care insurance, or via Medicaid waiver programs. Non-medical agencies face lighter regulatory requirements (no Medicare certification needed) but generally earn lower margins and have higher caregiver turnover because the work is lower-skilled and lower-paid.

Hospice

Hospice agencies provide end-of-life care for patients with a terminal prognosis of six months or less. Medicare’s hospice benefit covers room and board, nursing, counseling, pain management, and bereavement support under a per-diem rate that varies by level of care (routine home care, continuous home care, inpatient respite, and general inpatient). Hospice agencies tend to have the highest margins in home healthcare, EBITDA margins of 12-20% are common, but also face heightened regulatory scrutiny and complex billing rules.

Home infusion therapy

Home infusion companies administer IV medications (antibiotics, nutrition, chemotherapy, immunoglobulin) in the patient’s home. This niche requires specialized pharmacy licensure, nursing staff trained in infusion, and cold-chain logistics. Reimbursement comes from a mix of Medicare Part B, commercial insurance, and specialty pharmacy contracts. Home infusion is capital-intensive relative to other home health segments but commands higher per-patient revenue and is growing rapidly as biologic and specialty drugs proliferate.

Why home healthcare is attractive for ETA

Beyond the macro tailwinds, home healthcare has several structural features that make it particularly well-suited for the search fund model:

• Recurring, government-backed revenue: A Medicare-certified home health agency derives 60-80% of revenue from Medicare and Medicaid, payers that are slow to change but highly predictable. Reimbursement is not tied to advertising spend, consumer sentiment, or economic cycles.
• Extreme fragmentation: There are over 11,000 Medicare-certified home health agencies in the United States. The five largest operators account for less than 15% of the market. The vast majority of agencies are single-location businesses with $2M-$20M in revenue, exactly the size range where search funds operate.
• Aging ownership base: Many home health agencies were founded in the 1990s and 2000s by clinicians who are now approaching retirement without a succession plan, creating a steady supply of motivated sellers.
• Clear buy-and-build opportunity: Geographic adjacency, service-line expansion, and payer diversification provide natural add-on acquisition paths that can transform a single agency into a regional platform.
• Regulatory moat: Medicare certification, state licensure, Certificate of Need (CON) requirements in certain states, and accreditation create barriers to entry that protect incumbents from easy disruption.

Due diligence: what to examine

Home healthcare acquisitions require diligence that goes well beyond standard financial analysis. The items below are specific to the sector and should supplement your general healthcare acquisition guide and standard quality-of-earnings review.

Licenses and certifications

• State licensure: Every state requires home health agencies to hold a license issued by the state health department. Verify that the license is current, that there are no pending complaints or investigations, and that the ownership change will not trigger re-licensure.
• Medicare / Medicaid certification:If the agency bills Medicare, it must be certified by CMS and pass periodic surveys. Request the most recent survey results and any Plans of Correction (PoCs). A history of deficiencies , especially “condition-level” deficiencies , is a serious red flag.
• Accreditation: Many agencies hold voluntary accreditation from bodies such as the Joint Commission, ACHC, or CHAP. Accreditation is often required by commercial payers and can substitute for certain state survey requirements. Confirm accreditation status and expiration dates.
• Certificate of Need (CON): Approximately 15 states require a Certificate of Need to operate a home health agency. A CON can take 6-18 months to obtain, making it a significant barrier to entry, and a valuable asset if the target already holds one.

Payer mix analysis

The payer mix is arguably the single most important financial variable in a home health acquisition. Break down revenue by payer, Medicare traditional, Medicare Advantage, Medicaid fee-for-service, Medicaid managed care, commercial insurance, private pay, and track the trend over 36 months.

• Medicare Advantage risk:Medicare Advantage (MA) plans now cover more than half of all Medicare beneficiaries, and MA plans reimburse home health at rates that are 15-30% below traditional Medicare. A rapid shift from traditional Medicare to MA in the agency’s payer mix will compress margins even if patient volume holds steady.
• Medicaid rates: Medicaid reimbursement varies dramatically by state, from adequate to barely break-even. In states with low Medicaid rates, a heavy Medicaid mix can make the agency unprofitable at scale.
• Commercial and private-pay upside: Agencies with meaningful commercial and private-pay revenue typically command higher valuations because these payers reimburse at significantly higher rates.

Compliance history

Request the complete regulatory file: all CMS survey reports, state inspection results, Plans of Correction, any Office of Inspector General (OIG) investigations, and False Claims Act exposure. Home health has been a consistent focus of federal fraud enforcement, the OIG’s annual Work Plan regularly targets home health billing practices. Red flags include:

• Unusually high per-episode costs relative to regional averages
• High utilization of therapy visits (a historical audit trigger)
• Prior repayment demands or voluntary refunds to CMS
• Staff turnover in the compliance officer role
• Lack of a documented compliance program and training records

Staffing ratios and workforce metrics

Caregiver supply is the binding constraint in home healthcare. Evaluate the following workforce metrics during diligence:

1. Caregiver-to-patient ratio:Compare the agency’s staffing ratios to state minimum requirements and industry benchmarks. Understaffing limits the ability to accept new referrals and drives overtime costs.
2. Turnover rate: The national average annual turnover for home health aides exceeds 60%. An agency with turnover below 40% is performing well; above 80% signals serious compensation, culture, or management issues.
3. Vacancy rate: How many open positions does the agency have, and how long have they been unfilled? A chronically high vacancy rate limits growth capacity.
4. Contract labor dependency: Agencies that rely heavily on staffing agencies for clinical labor face higher costs and lower continuity of care. Transitioning from contract to employed staff is a common post-acquisition margin improvement lever.
5. Compensation benchmarks: Compare nurse and aide pay rates to local market data from the Bureau of Labor Statistics and industry salary surveys. Below-market pay is a predictor of elevated turnover.

Patient census and referral trends

Track the daily patient census (the number of patients under active care) over the trailing 24-36 months. A stable or growing census indicates healthy demand and referral relationships. A declining census requires immediate investigation, it may reflect lost referral sources, staffing shortages preventing new admissions, or competitive pressure. Identify the top 10 referral sources (hospitals, physician groups, skilled nursing facilities) and assess concentration risk. If a single referral source accounts for more than 25% of admissions, this represents a meaningful key-person risk that must be addressed in the acquisition structure.

Valuation benchmarks

Home healthcare valuations vary significantly based on certification status, payer mix, geography, and size. The ranges below reflect current market conditions:

• Medicare-certified agencies: 6-10x EBITDA is the prevailing range, with the wide spread driven by payer mix quality, census trends, survey history, and geographic desirability. Agencies in CON states command a premium because the certificate itself is a scarce, protected asset.
• Non-medical / companion care agencies:3-5x EBITDA. Lower multiples reflect lighter regulatory moats, higher caregiver turnover, and greater exposure to private-pay pricing pressure.
• Hospice agencies: 8-14x EBITDA for established agencies with strong compliance records. Hospice valuations have been bid up by PE-backed consolidators, making this segment more competitive for search fund buyers.
• Home infusion: 8-12x EBITDA, driven by specialty pharmacy revenue and high switching costs.

For Medicare-certified agencies, an alternative valuation approach uses revenue multiples, typically 0.8-1.5x trailing twelve-month revenue, which can be useful for agencies with temporarily depressed EBITDA due to investment in growth or one-time compliance remediation costs. Regardless of the multiple methodology, ensure you normalize EBITDA for owner compensation, related-party transactions, and any above-market lease payments to related entities.

Deal structure considerations

The legal structure of a home health acquisition has significant operational consequences:

• Stock vs. asset purchase: A stock purchase preserves the existing Medicare provider number, avoiding a gap in billing. An asset purchase may require the buyer to obtain a new provider number, a process that can take 60-120 days, during which the agency cannot bill Medicare. For this reason, most home health acquisitions are structured as stock or membership-interest purchases.
• Change of ownership (CHOW):CMS requires notification and approval for any change of ownership. The CHOW process includes review of the new owner’s qualifications, a potential re-survey, and verification that the agency meets all Conditions of Participation. Build 60-90 days into your closing timeline for CHOW processing.
• Escrow and holdbacks: Given the compliance risks inherent in healthcare, it is standard to hold 10-15% of the purchase price in escrow for 12-18 months to cover potential repayment demands, survey deficiencies, or undisclosed liabilities.
• Seller transition period: Clinical leadership continuity is critical during ownership transitions. Structure a 6-12 month consulting agreement with the seller to maintain referral relationships, staff confidence, and regulatory compliance during the management transition period.

Post-acquisition growth levers

Once you have closed the acquisition and stabilized operations, there are several proven strategies for growing a home healthcare platform. Our revenue growth playbook covers growth strategies in detail; the following are specific to home health.

Geographic expansion

Home health agencies are licensed by state and operate within defined service areas. Expanding into adjacent counties or metropolitan areas is the most straightforward growth lever. In non-CON states, this may require only a branch office notification to the state; in CON states, you may need to acquire an existing agency in the target geography or apply for a new certificate. Add-on acquisitions in neighboring service areas are the fastest path to geographic scale and form the backbone of a buy-and-build strategy in this sector.

Adding service lines

An agency that starts with skilled nursing can add physical therapy, occupational therapy, speech therapy, and medical social work to increase revenue per patient episode. Moving from skilled-only to non-medical companion care (or vice versa) creates cross-referral opportunities and deepens relationships with referral sources. Each new service line increases the agency’s value proposition to hospitals and physician groups that prefer to work with a single provider for all home-based services.

Caregiver recruitment and retention

Workforce capacity is the primary growth constraint in home healthcare. Operators who solve the staffing challenge gain market share by accepting referrals that competitors must decline. Winning strategies include:

• Offering above-market wages and benefits, even a $1-$2/hour premium over competitors can dramatically improve recruitment yield
• Providing consistent, full-time schedules rather than unpredictable per-visit assignments
• Investing in training and career ladders (CNA to LPN to RN programs)
• Building a culture of recognition, mentorship, and clinical support
• Implementing referral bonuses ($500-$1,000 per successful hire) to use existing staff networks
• Partnering with local nursing schools and CNA training programs for a pipeline of new graduates

Technology and EVV compliance

The 21st Century Cures Act mandates Electronic Visit Verification (EVV) for all Medicaid-funded personal care and home health services. EVV systems capture the type of service, the individual providing the service, the date and time, the location, and the individual receiving the service. Beyond regulatory compliance, technology adoption is a meaningful operational lever:

• Point-of-care documentation: Mobile applications that allow clinicians to complete visit notes, capture signatures, and submit documentation in real time reduce the lag between service delivery and billing, improving cash flow and reducing claim denials.
• Scheduling optimization: Route-optimization software reduces drive time between visits, increasing the number of visits per clinician per day and lowering mileage reimbursement costs.
• Remote patient monitoring (RPM): For Medicare-certified agencies, RPM devices (blood pressure cuffs, pulse oximeters, weight scales) can generate additional billable revenue while improving patient outcomes and reducing hospital readmissions.
• Integrated EMR and billing: A modern electronic medical record system that integrates clinical documentation, OASIS assessments, and billing workflows reduces errors, speeds up collections, and improves compliance audit readiness.

Payer diversification

Reducing concentration in any single payer is a strategic priority. Agencies that are overly dependent on traditional Medicare face margin compression as MA enrollment grows. Proactively contracting with Medicare Advantage plans, commercial insurers, and Medicaid managed care organizations , even at lower per-visit rates, diversifies revenue and reduces regulatory risk. Building a private-pay companion care division alongside a Medicare-certified skilled agency creates a blended model that is more resilient across reimbursement cycles.

Key risks and mitigants

• Reimbursement cuts: CMS adjusts Medicare home health rates annually, and the trend over the past decade has been downward in real terms. Mitigant: diversify payer mix, improve operational efficiency, and grow volume to offset rate compression.
• Regulatory enforcement: The OIG and state Medicaid Fraud Control Units actively investigate home health billing fraud. Mitigant: invest in a strong compliance program, conduct regular internal audits, and engage healthcare-specialized legal counsel.
• Workforce shortages: The Bureau of Labor Statistics projects a shortage of over 400,000 home health aides by 2030. Mitigant: compete on culture and compensation, invest in retention, and use technology to maximize the productivity of existing staff.
• Referral source concentration: Losing a major hospital referral partner can cause a sudden drop in admissions. Mitigant: diversify referral relationships, build direct-to-consumer marketing capabilities, and maintain consistently high patient satisfaction scores that make your agency the preferred discharge partner.
• Key-person dependency: In many small agencies, the founder holds the primary relationships with referral sources and clinical staff. Mitigant: structure a meaningful management transition period and build a leadership bench during the first year of ownership.

Building a regional platform

The fragmented nature of home healthcare makes it an ideal sector for a multi-location platform strategy. The playbook is straightforward:

1. Acquire a well-run platform agency with strong Medicare certification, clean compliance history, and a capable clinical leadership team. Pay 7-9x EBITDA for this foundation.
2. Build centralized back-office functions, billing, coding, HR, compliance, IT, that can absorb additional volume without proportional headcount increases.
3. Execute tuck-in acquisitionsof smaller agencies in adjacent geographies at 4-6x EBITDA. Integrate them onto the platform’s EMR, billing system, and compliance infrastructure.
4. Realize synergies through centralized billing (reducing denials and days in AR), group purchasing of medical supplies, shared clinical oversight, and elimination of duplicate administrative overhead.
5. Layer in new service lines (hospice, home infusion, private-duty nursing) across the entire network simultaneously, using existing referral relationships and patient populations.
6. Exit at platform multiples of 10-14x EBITDA to a larger strategic buyer, PE firm, or publicly traded home health company. The spread between tuck-in acquisition multiples (4-6x) and platform exit multiples (10-14x) is one of the most attractive arbitrage opportunities in ETA.

Quality metrics that matter

CMS publishes Home Health Star Ratings based on quality measures that directly affect referral volume and payer relationships. The metrics that matter most include:

• Acute care hospitalization rate: The percentage of patients who are hospitalized during a home health episode. Lower is better; top-quartile agencies achieve rates below 15%.
• Improvement in ambulation: A core functional outcome measure that affects Star Ratings.
• Timely initiation of care:The percentage of patients who receive their first skilled visit within 48 hours of referral. Hospitals strongly prefer agencies that demonstrate consistent, timely response.
• HHCAHPS patient satisfaction: The standardized patient experience survey for home health. Agencies with 4-5 Star Ratings on patient satisfaction have a significant competitive advantage in referral development.
• OASIS accuracy: The Outcome and Assessment Information Set is the clinical assessment tool used to determine Medicare reimbursement. Accurate OASIS scoring ensures appropriate reimbursement and reduces audit risk.

The bottom line

Home healthcare sits at the intersection of an unstoppable demographic wave and a healthcare system that is actively shifting care into the home. For search fund entrepreneurs, the opportunity is substantial: acquire a well-run, Medicare-certified agency in a fragmented market, stabilize operations, and build a regional platform through disciplined add-on acquisitions and service-line expansion. The regulatory complexity that deters less-prepared buyers is precisely what protects your investment and creates a durable competitive moat. Success requires assembling the right team , healthcare-specialized legal counsel, an experienced Director of Nursing, and a compliance officer who treats regulation as a competitive advantage rather than a burden. Get the fundamentals right, and home healthcare can deliver the rare combination of strong cash flow, downside protection, and meaningful long-term growth that every search fund investor seeks.

Frequently asked questions

What is the difference between skilled home health and non-medical home care?

Skilled home health agencies provide clinical services , nursing, physical therapy, occupational therapy, and speech-language pathology, under a physician’s plan of care. They bill Medicare under the Patient-Driven Groupings Model (PDGM) at approximately $2,000-$3,500 per episode and require Medicare certification. Non-medical home care agencies provide assistance with activities of daily living (bathing, dressing, meal preparation, companionship) and are typically paid out of pocket, through long-term care insurance, or via Medicaid waivers. Skilled agencies command higher margins and stronger valuations (6-10x EBITDA vs. 3-5x) but face heavier regulatory requirements. Many acquirers build platforms that combine both service lines to diversify payer mix and create cross-referral opportunities.

How does Medicare Advantage affect home health valuations?

Medicare Advantage (MA) plans now cover more than half of all Medicare beneficiaries, and they reimburse home health at rates 15-30% below traditional Medicare. An agency experiencing a rapid shift from traditional Medicare to MA in its payer mix will see margin compression even if patient volume holds steady. During due diligence, break down revenue by payer, traditional Medicare, MA, Medicaid, commercial, and private pay, and track the trend over 36 months. Agencies with diversified payer mixes and strong commercial or private-pay revenue command higher valuations because they are less exposed to any single reimbursement source.

What are the biggest risks in acquiring a home healthcare agency?

The primary risks are reimbursement cuts, regulatory enforcement, workforce shortages, and referral source concentration. CMS adjusts Medicare home health rates annually with a generally downward real trend. The OIG actively investigates billing fraud in home health, and deficient surveys can trigger provider enrollment holds. The Bureau of Labor Statistics projects a shortage of over 400,000 home health aides by 2030, making caregiver recruitment the binding growth constraint. If a single hospital referral source accounts for more than 25% of admissions, losing that relationship can cause a sudden census decline. Mitigate through payer diversification, strong compliance programs, competitive compensation, and broad referral network development.

Sources

• Centers for Medicare & Medicaid Services (CMS): “Medicare Home Health Data & Patient-Driven Groupings Model (PDGM) Overview,” 2024.
• IBISWorld, “Home Care Providers Industry in the US, Market Research Report,” 2024.
• Bureau of Labor Statistics: “Occupational Outlook Handbook: Home Health and Personal Care Aides,” 2024.